Key Quantitative Figures

  • Warrant Conversion: 19,85,000 equity shares of ₹10 each allotted on conversion of convertible warrants at premium of ₹112.50 per warrant
  • Total Proceeds from Conversion: ₹18,23,71,875 (Eighteen Crores Twenty Three Lakhs Seventy One Thousand Eight Hundred Seventy Five)
  • Outstanding Warrants: 45,00,000 convertible warrants remaining after conversion
  • Quarter Beginning Balance: ₹10,96,75,000 (Ten Crores Ninety Six Lakhs Seventy Five Thousand) available for utilization
  • Total Funds Raised Original: ₹79,44,00,000 from preferential issue of 64,85,000 convertible warrants
  • Total Utilized to Date: ₹34,78,54,705
  • Remaining Balance: ₹3,31,20,295

Dates of Action

  • Conversion Date: March 23, 2026 (as referenced in previous letter FVCIL/SEC/BSE/9794/2025-2026)
  • Quarter End: June 30, 2026
  • Audit Committee Meeting: August 11, 2026
  • Filing Date: August 11, 2026

Parties Involved

  • Listed Entity: Fundviser Capital India Limited (Scrip Code: 530197, Scrip ID: FUNDVISER)
  • Regulator: BSE Limited
  • Warrant Holders: One Promoter/Promoter Group holder and seven Non-Promoter holders
  • Subsidiaries: DARS Transtrade Private Limited, New India Re & Infra LLP, Starlight Box Theatres Private Limited
  • Company Officer: Prem Krishan Jain, Chairman & Managing Director (DIN: 09304822)

Fund Utilization Details

| Investment Object | Original Allocation | Utilized till 30/06/2026 | Deviation |

| Investment in DARS Transtrade Private Limited | ₹45,00,00,000 | ₹12,80,50,000 | Nil |

| Investment in New India Re & Infra LLP | ₹12,50,00,000 | ₹8,90,00,000 | Nil |

| Investment in Starlight Box Theatres Private Limited | ₹12,50,00,000 | ₹2,77,09,705 | Nil |

| General corporate purposes, working capital, future growth | ₹9,44,00,000 | ₹10,30,95,000 | Nil |

| Total | ₹79,44,00,000 | ₹34,78,54,705 | Nil |

Purpose and Rationale

The convertible warrants were issued with the object of making investments, meeting long-term funding requirements, working capital, general corporate purposes, etc. to support the future growth plan of the company.

Compliance Status

The company confirmed there are no deviations or variations in the use of proceeds for the quarter ended June 30, 2026, except for the deviation already declared and filed in the quarter and year ended March 31, 2026.

Audit Committee Review

The Audit Committee reviewed the statement in its meeting held on August 11, 2026 and did not offer any comments on the same. Auditors had no comments.

Shareholder Approval

Not applicable as no deviation occurred during the quarter.

Signature and Authentication

The document was digitally signed by Prem Krishan Jain, Chairman & Managing Director, on August 11, 2026 at 18:31:55 IST.